AZN
Astrazeneca plc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, renowned for its innovative research in the development of prescription medicines across critical therapeutic areas such as oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong and diverse ...
$203.49
+1.38% (+$2.76)
Volume
2.05M
52W High
$212.71
52W Low
$60.81
Market Cap
$291.47B
What to Watch This Quarter
Based on historical dataConsensus EPS
$2.50
Whisper EPS
$2.53
1.3% above consensus
Last Quarter
--
Current Streak
1 Beat
Avg Surprise (4Q)
-10.51%
Next Earnings Report
Reports in 28 days
Price Chart
EPS History: Consensus vs Actual
Last 4 quartersPrice Movement Around Earnings
Q4 2025
Feb 10, 2026
1-Day:
+5.87%
Q3 2025
Sep 30, 2025
1-Day:
+9.96%
Q2 2025
Jun 30, 2025
1-Day:
+2.26%
Q1 2025
Mar 31, 2025
1-Day:
-1.22%
Revenue & Financial Performance
Revenue Whisper
$16.15B
TWN Proprietary Estimate
Last Quarter Revenue
$15.50B
+4.1% YoY
Gross Margin
79.9%
Net Margin: 15.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $15.50B | +4.1% | 79.9% | 19.2% | $2.33B |
| Q3'25 | $15.19B | +12.0% | 81.6% | 23.6% | $2.53B |
| Q2'25 | $14.46B | +11.7% | 82.9% | 24.3% | $2.45B |
| Q1'25 | $13.59B | +7.2% | 83.5% | 27.0% | $2.92B |
| Q4'24 | $14.89B | +23.8% | 81.7% | 13.7% | $1.50B |
| Q3'24 | $13.57B | +18.0% | 77.3% | 15.5% | $1.43B |
| Q2'24 | $12.94B | +13.3% | 83.1% | 21.2% | $1.93B |
| Q1'24 | $12.68B | +16.6% | 82.5% | 24.6% | $2.18B |
Company Information
Symbol
AZN
Company
Astrazeneca plc
Market Cap
$291.47B
Sector
HEALTHCARE
Next Earnings
May 5, 2026
Also Reporting Soon
Companies reporting earnings around the same time as AZN
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare AZN with competitors
Side-by-side earnings comparison